Bicycle Therapeutics (BCYC) Operating Leases: 2019-2025
Historic Operating Leases for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $981,000.
- Bicycle Therapeutics' Operating Leases fell 82.27% to $981,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $981,000, marking a year-over-year decrease of 82.27%. This contributed to the annual value of $4.0 million for FY2024, which is 57.47% down from last year.
- Latest data reveals that Bicycle Therapeutics reported Operating Leases of $981,000 as of Q3 2025, which was down 44.42% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Operating Leases registered a high of $14.4 million during Q1 2023, and its lowest value of $981,000 during Q3 2025.
- Its 3-year average for Operating Leases is $6.9 million, with a median of $6.7 million in 2024.
- As far as peak fluctuations go, Bicycle Therapeutics' Operating Leases surged by 2,735.92% in 2021, and later tumbled by 82.27% in 2025.
- Bicycle Therapeutics' Operating Leases (Quarterly) stood at $12.1 million in 2021, then decreased by 9.90% to $10.9 million in 2022, then fell by 13.81% to $9.4 million in 2023, then crashed by 57.47% to $4.0 million in 2024, then tumbled by 82.27% to $981,000 in 2025.
- Its Operating Leases was $981,000 in Q3 2025, compared to $1.8 million in Q2 2025 and $2.6 million in Q1 2025.